NYSE: CNSCohen & Steers Inc Stock
$73.31-0.45 (-0.61%)
Updated May 17, 2024
CNS Price
$73.31
Fair Value Price
N/A
Market Cap
$3.71B
52 Week Low
$50.05
52 Week High
$78.58
P/E
28.31x
P/B
9.78x
P/S
7.84x
PEG
82.63x
Dividend Yield
3.16%
Revenue
$486.27M
Earnings
$127.74M
Gross Margin
89%
Operating Margin
35.38%
Profit Margin
26.3%
Debt to Equity
0.54
Operating Cash Flow
$192M
Beta
1.34
Next Earnings
Jul 17, 2024
Ex-Dividend
May 10, 2024
Next Dividend
May 23, 2024
CNS Overview
Cohen & Steers, Inc. is an asset management holding company. It takes equity stakes in real estate investment trusts, with holdings in U.S. and international real estate securities. The company also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. Cohen & Steers was founded in 1986 and is headquartered in New York, NY.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CNS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CNS ($73.31) is trading above its intrinsic value of $14.53, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CNS is good value based on its earnings relative to its share price (28.31x), compared to the US market average (30.97x)
P/E vs Market Valuation
CNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CNS due diligence checks available for Premium users.
Be the first to know about important CNS news, forecast changes, insider trades & much more!
CNS News
Valuation
CNS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.31x
Industry
28.21x
Market
30.97x
CNS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CNS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CNS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.78x
Industry
2.43x
CNS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CNS price to earnings growth (PEG)
For valuing profitable companies with growth potential
CNS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CNS's financial health
Profit margin
Revenue
$122.7M
Net Income
$34.0M
Profit Margin
27.7%
CNS's Earnings (EBIT) of $172.04M... subscribe to Premium to read more.
Interest Coverage Financials
CNS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$680.7M
Liabilities
$205.9M
Debt to equity
0.54
CNS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CNS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.9M
Investing
-$29.4M
Financing
-$64.3M
CNS's operating cash flow ($191.79M)... subscribe to Premium to read more.
Debt Coverage Financials
CNS vs Asset Management Stocks
Cohen & Steers Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.